Drs. Verhamme, Bauersachs and Davidson,
Thank you very much for participating in this Journal Club.
In the results, you talk about the number needed to treat to prevent one fatal or non-fatal recurrent venous thromboembolism without increasing the risk of bleeding, and report a number of 33 using 20 mg of rivaroxaban, and a number of 30 using 10 mg of rivaroxaban.
Given the high cost of rivaroxaban, do you think its use for DVT prophylaxis is cost effective?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.